GASTROINTESTINAL TUMOR
Clinical trials for GASTROINTESTINAL TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL TUMOR trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug BL-M02D1 takes first steps against tough cancers
Disease control OngoingThis early-phase trial is testing an experimental drug called BL-M02D1 in 22 people with advanced gastrointestinal or other solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and get a first look at whet…
Matched conditions: GASTROINTESTINAL TUMOR
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug candidate BL-M02D1 enters human trials for Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new drug called BL-M02D1 in people with advanced triple negative breast cancer or other solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors.…
Matched conditions: GASTROINTESTINAL TUMOR
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New imaging technique targets Hard-to-Find cancers
Diagnosis TerminatedThis study aimed to test a new two-step PET imaging method to better detect cancers that produce a substance called CA19-9, such as pancreatic, bladder, and gastrointestinal tumors. The plan was to give patients an antibody followed by a radioactive tracer to highlight cancer cel…
Matched conditions: GASTROINTESTINAL TUMOR
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 26, 2026 13:54 UTC